Company Filing History:
Years Active: 2022
Title: Sunghyun Choi: Innovator in Cancer Treatment
Introduction
Sunghyun Choi is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.
Latest Patents
Sunghyun Choi holds 1 patent for his work on anti-TIGIT antibodies. This patent discloses a novel antibody that specifically binds to the tumor-immunosuppressant, TIGIT (T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif [ITIM] domain). The patent also includes a nucleic acid encoding the antibody, a vector, and a host cell containing the nucleic acid. Furthermore, it outlines a method for producing the antibody and a pharmaceutical composition that includes the antibody as an active ingredient. The composition is particularly useful for the treatment of cancer or tumors.
Career Highlights
Sunghyun Choi is currently associated with Yuhan Corporation, where he continues to advance his research in immunotherapy. His work has the potential to significantly impact cancer treatment methodologies.
Collaborations
Sunghyun Choi collaborates with notable colleagues, including Kwang-Hoon Lee and June Hyung Lee, to further enhance the development of innovative therapeutic solutions.
Conclusion
Sunghyun Choi's contributions to the field of cancer treatment through his patented innovations highlight his role as a key inventor in the medical research community. His work exemplifies the importance of innovation in addressing critical health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.